Loading…
Icon PLC
Icon PLC (ICLR) is listed on NASDAQ and classified in Diagnostics & Research, part of the Healthcare sector. It is headquartered in Dublin, Ireland and has 40,200 employees. The company is worth $14.31B and trades at 195.2x its earnings of the last twelve months; the median for its sector is 24.3x. Revenue was $8.25B in fiscal 2025, up 0.8% from the year before. Net income was $229.34M. The share price is 9.1% below its 52-week high of $203.91. None of the 38 superinvestors we track reported it in their latest 13F. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in ICLR.
▼ -37.1% over 5Y.
today you would have $593.44▼ -40.7%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 18 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $182.22 | $209.71 | $283.07 | $194.25 | $309.70 | $194.98 | $172.23 | $129.21 | $112.15 | $75.20 | $77.70 | $50.99 | $40.42 | $27.76 | $17.11 | $21.90 | $21.73 | $19.69 |
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
Square root of 22.5 × earnings × book value. Blind to intangibles, so it undervalues software and brands.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Median P/E of 24.3 among peers in the sector.
Median P/E of 24.0 across this company’s own years on record.
Cash flow growing 5.0% a year for 10 years, discounted at 10%, then 2.5% forever.
Sector median of 14.1x operating profit, less net debt. Banks have no EBITDA.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| HALOHalozyme Therapeutics Inc | $124.54 | 36.5x | 98.9x | 0.00% | 173.67% | $14.14B |
| NBIXNeurocrine Biosciences Inc | $143.29 | 20.7x | 3.9x | 0.00% | 22.09% | $14.57B |
| JAZZJazz Pharmaceuticals plc | $214.65 | 14.5x | 2.9x | 0.00% | 22.11% | $13.93B |
| SOLVSolventum Corp |
| P/E | 24.0x | 62.8x | 23.6x | 42.2x | 31.7x | 137.6x | 31.7x | 25.4x | 21.9x | 21.9x | 16.2x | 19.6x | 18.7x | 24.5x | 30.2x | 46.2x | 15.2x | 13.8x | 15.1x |
| P/S | 2.1x | 1.7x | 2.1x | 2.9x | 2.1x | 4.6x | 3.7x | 3.3x | 2.7x | 3.4x | 2.5x | 2.7x | 2.0x | 1.9x | 1.5x | 1.1x | 1.5x | 1.4x | 1.3x |
| P/B | 2.6x | 1.5x | 1.8x | 2.5x | 1.9x | 3.1x | 5.6x | 5.7x | 5.1x | 5.1x | 4.3x | 5.6x | 3.2x | 2.7x | 2.2x | 1.5x | 2.0x | 2.2x | 2.5x |
| EPS | $2.90 | $8.90 | $6.70 | $6.13 | $2.25 | $6.15 | $6.79 | $5.89 | $5.13 | $4.65 | $3.97 | $2.73 | $1.65 | $0.92 | $0.37 | $1.44 | $1.57 | $1.30 |
| Profit margin | 9.35% | 2.78% | 9.03% | 6.88% | 6.53% | 2.79% | 11.88% | 13.33% | 12.43% | 16.01% | 15.73% | 15.21% | 11.47% | 7.70% | 4.97% | 2.42% | 9.67% | 10.62% | 9.03% |
| ROE | 14.74% | 2.49% | 7.83% | 6.02% | 5.93% | 1.90% | 17.96% | 23.11% | 23.82% | 23.63% | 27.74% | 31.39% | 18.15% | 11.29% | 7.34% | 3.36% | 13.00% | 16.48% | 17.12% |
Median of the years shown; P/E years above 200x are left out.
The average of the method families that answered, not of the seven numbers: four of the seven start from the same earnings per share.
5 methods answered, across 3 families.
Room for errors in the reported numbers.
-44.2% from the average.
Models, not forecasts, and not investment advice. How each formula works →
| $87.45 |
| 10.6x |
| 3.1x |
| 0.00% |
| 33.96% |
| $14.89B |
| BBIOBridgeBio Pharma, Inc. | $68.12 | — | — | 0.00% | — | $13.32B |
| BAXBaxter International Inc | $25.65 | — | 2.1x | 0.16% | -14.37% | $13.26B |